BSE Live
Oct 20, 16:01Prev. Close
826.20
Open Price
830.80
Bid Price (Qty.)
834.00 (5)
Offer Price (Qty.)
835.50 (28)
NSE Live
Oct 20, 15:58Prev. Close
826.20
Open Price
836.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
833.65 (10)
Cash Flow of Natco Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 583.10 | 847.40 | 887.60 | 634.10 | 221.50 | |
Net CashFlow From Operating Activities | 422.50 | 698.80 | 476.40 | 329.80 | 189.90 | |
Net Cash Used In Investing Activities | -165.00 | -645.20 | -1,131.10 | -290.60 | -249.30 | |
Net Cash Used From Financing Activities | -261.10 | -52.20 | 652.00 | -45.60 | 151.40 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 1.20 | |
Net Inc/Dec In Cash And Cash Equivalents | -3.60 | 1.40 | -2.70 | -6.40 | 93.20 | |
Cash And Cash Equivalents Begin of Year | 11.50 | 10.10 | 12.80 | 19.20 | -170.00 | |
Cash And Cash Equivalents End Of Year | 7.90 | 11.50 | 10.10 | 12.80 | -76.80 |
14.10.2025
Natco Pharma shares fall 3.5% as SC agrees to urgently list Roche's plea on Risdiplam launch
10.10.2025
Natco Pharma shares jump 6% after Delhi HC allows firm to sell 'Risdiplam' in India
10.10.2025
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y
05.06.2025
Natco Pharma Standalone March 2025 Net Sales at Rs 1,157.40 crore, up 19.96% Y-o-Y
03.06.2025
Natco Pharma Consolidated March 2025 Net Sales at Rs 1,221.00 crore, up 14.29% Y-o-Y
28.02.2025
Natco Pharma Consolidated December 2024 Net Sales at Rs 474.80 crore, down 37.41% Y-o-Y